Biomimetic LNPs for Enhanced Targeting of Inflamed Tissue: What Are the Challenges? Published 2022-11-21 Download video MP4 360p Recommendations 21:40 Quantification of Phospholipid-based Drug Delivery Systems: Where do we Stand? 45:00 Accelerate development by outsourcing MRNA–LNP formulations to a CDMO 23:48 CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle Platform 54:36 Lipid nanoparticle-mediated delivery of CRISPR components for neuronal genome editing 38:49 Novel Ionizable Lipid Portfolio for Enabling Non-Viral Delivery 45:23 New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy 24:36 Manufacture of LNPs for RNA delivery 43:40 Optimized and Scalable LNP Composition for RNA Vaccine Delivery 1:01:44 Maximizing Yield and Purity in RNA-LNP Downstream Processing 58:58 Clinical and Commercial Manufacturing of mRNA Therapeutics: Opportunities and Challenges 23:44 Elon Musk's Bionic Eyes Are Here. 38:42 Standardizing Scale-up: Insights into Producing Clinical and Commercial RNA-LNP Drug Products 3:54:38 Optogenetics: Illuminating the Path toward Causal Neuroscience 1:56:10 Sunlight: Optimize Health and Immunity (Light Therapy and Melatonin) 02:01 How Lipid Nanoparticles (LNPs) Dutifully Deliver mRNA 01:55 Lipid Nanoparticles (LNPs) for mRNA Delivery | What are Lipid Nanoparticles? 02:54 Ionizable Lipids to Optimize RNA-LNP Delivery 16:17 How to Cope with Rumination: Don't Feed the “Demon” (Default Mode Network) 03:33 Nano Particle synthesis 02:25 NanoAssemblr Commercial Formulation System Overview Similar videos 50:32 West Webinar: A Biomimetic Liposomal Formulation for the Targeting of Inflamed Vasculature 14:26 Robust low-volume production of lipid nanoparticles for nucleic acid drug discovery & screening 18:58 Endosomal Escape of Lipid Nanoparticles: Novel Insights Using Reflectivity Techniques 22:41 Building an LNP process for the Omega platform: a case study 33:00 Lipid Based Nanomedicine - Challenges that Lead to Solutions presented by Dr. Marcel Bally 23:24 Transient Expression of mRNA-LNP-based Chimeric Antigen Receptors for Safe Immunotherapy 22:09 How Cell Heterogeneity Influences LNP-Mediated mRNA Delivery - Dr. Kalina Paunovska 1:00:07 Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid Nanoparticles 28:59 Therapeutic RNAs Delivery to Leukocytes presented by Dr. Dan Peer 20:40 Developing a platform process for LNP manufacture 21:41 Leukolike Technology to Avoid Nanoparticle Recognition by the Immune System 30:57 RNA Nanotherapeutics for Cardiovascular Disease - John Cooke, HMRI 23:06 Targeting the Number One Killer, Atherosclerosis - Repair Biotechnologies | Lifespan.IO 56:32 How RNA Therapeutics will Change Cardiovascular Medicine (John P. Cooke, MD) December 21, 2020 56:18 Cardiovascular Regeneration Conference, Journal Club and Progress Report (April 21, 2017) 23:02 Anti‐Inflammatory Liposomes in Oncology 16:20 Technology Platform for the Production of Lipid‐based Nanovesicles as New Nanomedicines 46:06 Democratizing RNA Nanotherapeutics More results